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The paper describes topological modeling of antimycobacterial activity of 3-formyl rifamycin 
SV derivatives using a large series of  molecular vis-à-vis topological descriptors. For the set of 
53 derivatives of 3-formyl rifamycin SV no one variable model is possible, however, in 
multiparametric regression excellent model is obtained for modeling the activity. The results are 
discussed using variety of statistical parameters. 
 






Rifamycins are a group of chemically related antibiotics obtained from Streptomyces 
mediterrani. They belong to a new class of antibiotics that contain a macrocyclic ring bridged 
across two non-adjacent (ansa) portions of an aromatic nucleus and called ansamycins [1]. The 
rifamycins and many of their semi-synthetic derivatives have a broad spectrum of anti-microbial 
activity [1,2]. They are most notably active against gram-positive bacteria and Mycobacterium 
tuberculosis. However, they are also active against some gram-negative bacteria and many 
viruses. They form a class of antibiotics with a specific potency as drug against tuberculosis via 
inhibition of the DNA-dependent RNA polymerase [3]. Rifamycin SV (which lacks a C-4 
constituent) and the glycolic acid linked at C-3 has antibacterial activity. 3-formyl rifamycin 
derivatives (Table 1) are one of the classes of anzamycins widely used against infections caused 
by ordinary bacteria, tuberculosis and leprosy [4]. In the present study the antibacterial potency, 
log(MICRIA / MICX),  of this class of compounds (Fig.1, Table 1) against Mycobacterium 
tuberculosis are subjected to a QSAR analysis using a large set of topological indices (Tables 2 
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and  3).In these tables as well as in the text this activity is shown as logA. The QSAR modeling 
is then performed by maximum-R2 method using step-wise regression analysis [5-7]. The results 
are discussed below. 
 
Table 1. Structural details of the compounds used in the present study 
Comp R Comp R Comp R 
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Figure 1. General structure of the compounds used in this study. 
 
Table 2.  Topological descriptors used in this study 
 Symbol Definition 
1 X0A Average connectivity index chi-0 
2 X5AV Average valence connectivity index chi-5 
3 BAC Balaban centric index 
4 IDDE Mean information content on the distance degree equality 
5 BIC4 Bond information content (neighborhood symmetry of 4-order) 
6 LP1 Lovasz-Pelikan index (leading eigen value) 
7 EIG1M Leading eigen value from mass weighted distance matrix  
8 SEIGE Eigen value sum from electronegativity weighted distance matrix 
9 VEA1 Eigen vector coefficient sum from adjacency matrix  
10  VRE2 Average Randic-type eigen vector-based index from 
electronegativity weighted distance matrix  
11 VEP2 Average eigen vector coefficient sum from polarizability weighted 
distance matrix  
12 VRP1 Randic-type eigen vector-based index from polarizability weighted 
distance matrix  
13 MPC09 Molecular path count of order 09 
14 MPC10 Molecular path count of order 10 
15 PIPC10 Molecular multiple path count of order 10 
 
Table 3. Observed activity (logA) and topological descriptors used in this study 
Comp. BIC4 LP1 VEA1 X5Av VRE2 IDDE MPC09 logA 
1 0.88 2.638 4.578 0.022 7.958 5.277 376 0.645 
2 0.881 2.638 4.578 0.022 7.977 5.277 376 -1.053 
3 0.866 2.644 4.708 0.022 8.232 5.527 423 -1.028 
4 0.877 2.639 4.660 0.022 8.591 5.617 457 -1.011 
5 0.885 2.639 4.678 0.022 8.672 5.679 466 -1.003 
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6 0.885 2.639 4.669 0.022 8.678 5.679 464 -1.003 
7 0.875 2.639 4.667 0.023 8.685 5.611 465 -1.003 
8 0.877 2.639 4.667 0.023 8.681 5.611 465 -0.992 
9 0.882 2.639 4.694 0.022 9.003 5.825 505 -0.286 
10 0.886 2.639 4.667 0.022 8.675 5.611 465 -1.010 
11 0.884 2.639 4.661 0.023 8.516 5.420 453 -1.008 
12 0.876 2.639 4.660 0.022 8.589 5.617 457 -0.612 
13 0.880 2.639 4.601 0.022 8.058 5.351 391 -0.347 
14 0.881 2.639 4.612 0.022 8.153 5.194 405 -1.038 
15 0.880 2.639 4.641 0.022 8.683 5.611 445 -0.605 
16 0.881 2.639 4.631 0.023 8.786 5.402 439 0.005 
17 0.887 2.639 4.620 0.022 8.357 5.401 418 -0.322 
18 0.867 2.639 4.630 0.022 8.241 5.563 419 0.970 
19 0.863 2.639 4.646 0.022 8.427 5.420 435 1.588 
20 0.859 2.639 4.653 0.023 8.614 5.578 445 1.001 
21 0.856 2.639 4.657 0.024 8.799 5.689 453 0.015 
22 0.877 2.639 4.669 0.022 8.753 5.436 459 1.607 
23 0.868 2.639 4.661 0.022 8.522 5.42 453 0.382 
24 0.870 2.639 4.660 0.024 8.614 5.617 457 -0.008 
25 0.864 2.639 4.660 0.025 8.697 5.578 459 0.397 
26 0.879 2.639 4.631 0.022 8.767 5.402 439 -0.297 
27 0.888 2.639 4.669 0.024 8.698 5.679 464 0.001 
28 0.870 2.639 4.660 0.023 8.609 5.617 457 0.391 
29 0.876 2.639 4.678 0.025 8.871 5.800 474 -0.588 
30 0.871 2.639 4.660 0.023 8.611 5.617 457 -0.610 
31 0.869 2.639 4.667 0.024 8.707 5.611 465 0.000 
32 0.865 2.640 4.734 0.025 9.336 5.772 523 0.449 
33 0.873 2.639 4.644 0.023 8.734 5.469 440 0.001 
34 0.876 2.639 4.661 0.022 8.506 5.420 453 -1.017 
35 0.884 2.639 4.626 0.022 8.333 5.365 421 -1.022 
36 0.885 2.639 4.626 0.022 8.334 5.365 421 -1.022 
37 0.878 2.639 4.671 0.024 8.901 5.761 455 -0.264 
38 0.884 2.639 4.465 0.022 8.845 5.800 447 -0.988 
39 0.882 2.639 4.601 0.022 8.057 5.351 391 -1.046 
40 0.879 2.639 4.612 0.022 8.147 5.194 405 0.032 
41 0.874 2.639 4.626 0.023 8.896 5.800 436 0.017 
42 0.879 2.639 4.631 0.022 8.777 5.402 439 -0.011 
43 0.872 2.639 4.631 0.024 8.789 5.402 439 0.006 
44 0.871 2.639 4.631 0.023 8.699 5.611 437 -0.001 
45 0.867 2.639 4.631 0.025 8.869 5.767 441 -0.589 
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46 0.872 2.639 4.631 0.023 8.784 5.402 439 -0.294 
47 0.870 2.639 4.624 0.022 8.426 5.456 423 -0.316 
48 0.866 2.639 4.628 0.022 8.611 5.611 431 -0.301 
49 0.862 2.639 4.629 0.023 8.791 5.767 435 -0.286 
50 0.874 2.639 4.633 0.025 8.956 5.793 441 0.016 
51 0.881 2.639 4.630 0.023 9.018 5.680 439 -0.576 
52 0.884 2.639 4.627 0.023 8.726 5.469 430 -0.595 
53 0.857 2.639 4.637 0.023 8.929 5.616 443 -0.574 
 
 
Results and Discussion 
 
So far, no QSAR studies with rifamycins employing molecular descriptors mentioned in Table 3 
were used to quantify and elucidate potentially relevant chemical reactivity patterns of the drugs. 
The literature data on the antibacterial potential of 3-formylrifamycin SV derivatives (Table 3) 
was used for preparing models with excellent statistics. The correlation of the antibacterial 
activity with the molecular descriptors used is given in Table 4.  
 A preliminary regression analysis (Table 5) has indicated that none of the molecular 
descriptors used singly is capable of modeling the activity. However, the data presented in Table 
5 did show that the variable BIC4 (Bond information content, neighborhood symmetry of 4-
order) is the promising descriptor to be used in multiparametric regression analysis. It means that 
multiparametric model(s) will invariably contain this BIC4 as one of the correlating parameters. 
 Before a multivariate analysis is undertaken it is convenient to normalize the data in certain 
ways in order to make the detection of significant correlations easier. Normally, it is sufficient to 
preprocess the data by means of auto-scaling and mean-centering the variables. Auto-scaling 
gives each variable unit variance and hence the same chance to contribute to a estimated model, 
while mean-scaling facilitates interpretation. This can be achieved by obtaining correlation 
matrix. Such a correlation matrix, as stated earlier, is presented in Table 4. An examination of the 
correlation matrix (Table 4) shows molecular descriptors used did exhibit linear correlation. That 
is, model containing such descriptors will suffer from the defect due to collinearity, which 
statistically is not allowed. Such cases will be examined using Randic [8] recommendations 
discussed in the following section. 
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Table 4. Correlation matrix for the activity and the descriptors used in this study 
 logA X0A X5AV BAC IDDE BIC4 LP1 EIG1M 
logA 1               
X0A 0.02475 1             
X5AV 0.14924 -0.33202 1           
BAC 0.08723 0.74611 0.02572 1         
IDDE -0.02787 -0.49132 0.53572 0.03119 1       
BIC4 -0.48497 -0.11430 -0.41367 -0.39190 -0.28160 1     
LP1 -0.12101 0.08337 0.00468 0.18069 0.10776 -0.22259 1   
EIG1M 0.13101 -0.55892 0.59003 0.07632 0.73316 -0.28776 0.00823 1 
SEIGE -0.14140 0.06136 0.10853 0.12272 0.09245 0.06470 0.12629 0.13724 
MPC09 0.05653 -0.72254 0.41573 -0.17874 0.68451 -0.17186 0.11975 0.68341 
MPC10 0.04380 -0.73795 0.43449 -0.18817 0.69658 -0.15014 0.08270 0.70535 
PIPC10 -0.23741 -0.61839 0.07881 -0.20740 0.54719 0.09777 0.00523 0.49300 
VEA1 0.02565 -0.50512 0.31264 -0.04970 0.57028 -0.22145 0.50043 0.45412 
VRP1 0.11257 -0.62598 0.57586 0.02053 0.76045 -0.26281 0.02914 0.98667 
VEP2 -0.11631 0.60096 -0.54522 -0.04721 -0.75140 0.26808 -0.02621 -0.97364 
VRE2 0.09404 -0.69116 0.57202 -0.06009 0.76779 -0.22689 0.01303 0.97269 
 SEIGE MPC09 MPC10 PIPC10 VEA1 VRP1 VEP2 VRE2 
SEIGE 1               
MPC09 -0.13777 1             
MPC10 -0.11535 0.99600 1           
PIPC10 -0.19410 0.80463 0.79886 1         
VEA1 -0.11275 0.88633 0.86689 0.65296 1       
VRP1 0.14575 0.76749 0.78848 0.59164 0.54933 1     
VEP2 -0.17184 -0.76815 -0.78914 -0.60826 -0.55057 -0.99212 1   
VRE2 0.10937 0.80628 0.82737 0.63707 0.58025 0.99511 -0.98697 1 
 
 Following maximum-R2 method [5-7], and using a large set of 15 descriptors and the entire 
set of 53 compounds, we obtained several models containing 1 to 10 correlating parameters 
(Table 5) and observed that the models contains compounds 27, 31, 33, 43 and 44 as outliers. 
The deletion of these compounds gave better results (Table 6). A perusal of Table 6 shows that 
statistically better models start from model-25. A detailed analysis of these models (Table 7) 
indicates that they contain one or more correlating parameters in that the coefficient of the 
correlating parameter is significantly smaller than their respective standard deviation. Such 
models are not allowed statistically. The deletion of such parameters from the models yielded 
improved models 33-38 as presented in Table 8. Hence, our further discussion will be centered 
on these six models: 33-38.The data presented in Tables 8 and 9 indicate that the model 38 is the 
best model for modeling the antibacterial activity.  
 It is interesting to mention that the model 38 contains 12 correlating parameters. It becomes 
necessary to examine the model 38 by applying the rule of thumb [9,10] and searching optimum 
descriptors that can be used in proposing the models for the data set of 53 (reduced to 48 after 
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removing five outliers) compounds used in the present study. The limitations and some common 
pitfalls of multiple regression analysis were pointed out by Tute [9,10]. According to him, there 
must be a sufficient number of compounds included in the analysis to enable statistical 
significance to be reached, despite inevitable errors in measurement. A rule of thumb evolved by 
Tute [9,10] is that the number compounds to be used should be at least three times the number of 
parameters under consideration. Looking to the data set (48 compounds) and in accordance with 
the rule of thumb the proposed 12 parametric model is quite justified. In order to confirm this 
finding we have investigated optimum number of parameters that could be used for modeling the 
activity of 48 compounds. This we did by plotting graphs between the number of variables and 
the corresponding R2 and R2A values [Table 10 ] plotted on the same graph. In our case both R2 
and R2A go on increasing with the number of variables and becomes almost constant at 12 
parameters. This finding is, therefore, consistent with the results obtained by applying the rule of 
thumb [9, 10]. Further confirmation is made by calculating the activities from each of the 
proposed models and comparing them with the experimental (observed) activities. Such 
comparisons are given in Table 11 and demonstrated in Figures 2-7. The results are in favor of 
12 parametric model 38. We have also used the data from Figures 2-7 and obtained correlations 
between observed and estimated antibacterial activity. This demonstrated by models 39-44 
(Table 12), which finally confirmed that the proposed 12 parametric model 38 is the most 
appropriate model for modeling the activity. 
 
Table 5. Model summary considering all the 53 Compounds 










df1 df2 Sig. F 
Chang
e 
1 0.481 0.231 0.216 0.68767 0.231 16.314 1 61 0.000 
2 0.519 0.269 0.240 0.57865 0.038 2.602 1 50 0.113 
3 0.581 0.338 0.297 0.55626 0.069 5.106 1 49 0.028 
4 0.613 0.375 0.323 0.54592 0.037 2.873 1 48 0.097 
5 0.645 0.416 0.353 0.53363 0.040 3.237 1 47 0.078 
6 0.664 0.441 0.368 0.52741 0.026 2.116 1 46 0.153 
7 0.683 0.467 0.384 0.52088 0.026 2.161 1 45 0.149 
8 0.693 0.480 0.386 0.52017 0.013 1.122 1 44 0.295 
9 0.719 0.517 0.416 0.50716 0.037 3.286 1 43 0.077 
10 0.712 0.506 0.417 0.50684 -0.011 0.945 1 45 0.336 
11 0.764 0.584 0.497 0.47082 0.077 7.991 1 43 0.007 
12 0.763 0.582 0.606 0.46621 -0.001 0.143 1 45 0.707 
13 0.787 0.620 0.541 0.44985 0.038 4.259 1 43 0.045 
14 0.797 0.635 0.548 0.44639 0.015 1.670 1 42 0.203 
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Table 6. Model summary for the set of 48 compounds after deleting five compounds( 26,31,33, 
43 and 44) as outliers 
Change Statistics Model R R2 Adjusted 
R2 
Std. error 






df1 df2 Sig. F 
Change 
15 0.480 0.235 0.219 0.61086 0.235 14.146 1 46 0.000 
16 0.639 0.290 0.259 0.69492 0.055 3.948 1 45 0.068 
17 0.570 0.324 0.278 0.58705 0.034 2.216 1 44 0.144 
18 0.633 0.400 0.345 0.55940 0.076 4.457 1 43 0.024 
19 0.655 0.429 0.362 0.55215 0.029 2.136 1 42 0.151 
20 0.684 0.468 0.391 0.53942 0.039 3.006 1 41 0.090 
21 0.702 0.493 0.404 0.63355 0.024 1.906 1 40 0.175 
22 0.720 0.518 0.419 0.52669 0.025 2.049 1 39 0.160 
23 0.746 0.556 0.451 0.51193 0.038 3.281 1 38 0.078 
24 0.769 0.591 0.481 0.49782 0.035 3.186 1 37 0.082 
25 0.792 0.627 0.513 0.48203 0.036 3.464 1 36 0.071 
26 0.809 0.655 0.536 0.47065 0.027 2.761 1 35 0.106 
27 0.805 0.649 0.541 0.46797 -0.006 0.591 1 37 0.447 
28 0.812 0.660 0.543 0.46705 0.011 1.142 1 35 0.283 
29 0.810 0.656 0.551 0.46281 -0.003 0.350 1 37 0.558 
30 0.820 0.673 0.561 0.45795 0.017 1.770 1 35 0.192 
31 0.866 0.750 0.654 0.40644 0.077 10.433 1 34 0.003 
32 0.865 0.748 0.661 0.40237 -0.002 0.303 1 36 0.586 
 
Table 7. Details of the statistically significant models 25-32 
 
Regression Equation for Model No.25 : 
logA = 2150.474 (+ 665.214) – 29.953 (+ 11.254) BIC4 – 885.635 (+ 279.172) LP1  
 – 0.001 (+ 0.000) PIPC10 + 38.664 (+ 17.006) VEA1  
 – 251.831 (+ 108.540) X5AV + 8.836 (+ 2.766) VRE2 – 0.745 (+ 0.703) IDDE – 0.097 (+ 
0.032) MPC10 + 8.712E-02 (+ 0.039) MPC09  
 – 0.036 (+ 0.015) EIG1M – 0.993 (+ 0.534) SEIGE 
 
Regression Equation for Model No.26 : 
logA = 2056.90 (+ 651.954) – 20.756 (+ 12.303) BIC4 – 825.621 (+ 274.967) LP1  
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 – 0.001 (+ 0.000) PIPC10 + 34.753 (+ 16.771) VEA1  
 – 208.754 (+ 109.104) X5AV + 7.115 (+ 2.893) VRE2 – 0.536 (+ 0.698) IDDE – 104 (+ 
0.032) MPC10 + 0.100 (+ 0.039) MPC09 – 0.048 (+ 0.016) EIG1M  
 – 1.553 (+ 0.620) SEIGE – 287.448 (+ 172.991) VEP2 
 
Regression Equation for Model No.27 : 
logA = 2012.690 (+ 645.707) – 18.799 (+ 11.968) BIC4 – 805.358 (+ 272.139) LP1  
 – 0.001 (+ 0.000) PIPC10 + 32.763 (+ 16.475) VEA1  
 – 223.505 (+ 106.790) X5AV + 7.027 (+ 2.874) VRE2  
 – 0.107 (+ 0.031) MPC10 + 0.105 (+ 0.038) MPC09 – 0.050 (+ 0.016) EIG1M  
 – 1.649 (+ 0.604) SEIGE – 311.397 (+ 169.190) VEP2 
 
Regression Equation for Model No.28 : 
logA = 1737.177 (+ 694.112) – 15.240 (+ 12.401) BIC4 – 682.864 (+ 294.809) LP1  
 – 0.001 (+ 0.000) PIPC10 + 22.802 (+ 18.902) VEA1  
 -210.345 (+ 107.289) X5AV + 2.862 (+ 4.840) VRE2 - 0.103 (+ 0.031) MPC10 + 0.111 (+ 
0.038) MPC09 – 0.070 (+ 0.024) EIG1M  – 1.984 (+ 0.680) SEIGE – 242.243 (+ 180.837) 
VEP2 + 5.150E-02 (+ 0.048) VRP1 
 
Regression Equation for Model No.29 : 
logA = 1561.558 (+ 621.704) – 12.979 (+ 11.690) BIC4 – 602.395 (+ 259.165) LP1  
 – 0.001 (+ 0.000) PIPC10 + 16.683 (+ 15.675) VEA1  
 -193.821 (+ 102.648) X5AV + 0.097 (+ 0.029) MPC10  
 + 0.112 (+ 0.038) MPC09 – 0.075 (+ 0.023) EIG1M  – 2.109 (+ 0.640) SEIGE – 232.542 
(+ 178.458) VEP2 + 7.446E-02 (+ 0.028) VRP1 
 
Regression Equation for Model No.30 : 
logA = 2168.174 (+ 765.755) – 18.004 (+ 12.168) BIC4 – 854.825 (+ 319.015) LP1  
 – 0.001 (+ 0.000) PIPC10 + 35.663 (+ 21.075) VEA1  
 -200.192 (+ 101.681) X5AV + 0.105 (+ 0.030) MPC10  
 + 0.101 (+ 0.039) MPC09 – 0.057 (+ 0.026) EIG1M  – 1.922 (+ 0.649) SEIGE – 319.790 
(+ 188.368) VEP2 + 5.379E-02 (+ 0.032) VRP1 
 - 0.004 (+ 0.003) BAC 
 
Regression Equation for Model No.31 : 
logA = 1565.801 (+ 704.755) – 25.565 (+ 11.050) BIC4 – 753.356 (+ 284.874) LP1  
 – 0.001 (+ 0.000) PIPC10 + 28.792 (+ 18.825) VEA1  
 -283.412 (+ 93.851) X5AV + 0.087 (+ 0.027) MPC10  
 + 0.106 (+ 0.034) MPC09 – 0.060 (+ 0.023) EIG1M  – 1.804 (+ 0.577) SEIGE – 99.386 (+ 
180.573) VEP2 + 9.821E-02 (+ 0.032) VRP1 
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 - 0.045 (+ 0.013) BAC + 440.470 (+ 136.371) X0A 
 
Regression Equation for Model No.32 : 
logA = 1445.987 (+ 663.583) – 27.100 (+ 10.586) BIC4 – 717.297 (+ 274.463) LP1  
 – 0.001 (+ 0.000) PIPC10 + 25.844 (+ 17.866) VEA1  
 – 298.788  (+ 88.700) X5AV + 0.083 (+ 0.026) MPC10  
 + 0.106 (+ 0.034) MPC09 – 0.063 (+ 0.023) EIG1M  – 1.734 (+ 0.557) SEIGE + 0.109 (+ 
0.024) VRP1 - 0.047 (+ 0.012) BAC + 468.834 (+ 124.995) X0A 
 
Table 8.  Regression equations for the improved models( 33-38) 
Regression Equation for Model No.33 : 
logA = 2049.932 (+ 698.808) – 37.840 (+ 11.254) BIC4 – 844.769 (+ 293.312) LP1  
 – 0.001 (+ 0.000) PIPC10 + 42.459 (+ 17.817) VEA1  
 – 252.244 (+ 114.282) X5AV + 7.304 (+ 2.822) VRE2  
 – 0.036 (+ 0.018) MPC10 – 0.028 (+ 0.016) EIG1M – 1.059 (+ 0.561) SEIGE 
 - 0.950 (+ 0.734) IDDE 
 
Regression Equation for Model No.34 : 
logA = 2012.690 (+ 645.707) – 18.799 (+ 11.968) BIC4 – 805.358 (+ 272.139) LP1  
 – 0.001 (+ 0.000) PIPC10 + 32.763 (+ 16.475) VEA1  
 – 223.505 (+ 106.790) X5AV + 7.027 (+ 2.874) VRE2  
 – 0.107 (+ 0.031) MPC10 + 0.050 (+ 0.016) EIG1M  – 1.649 (+ 0.604) SEIGE + 0.105 (+ 
0.038) MPC09 - 311.397 (+ 169.190) VEP2 
 
Regression Equation for Model No.35 : 
logA = 1561.558 (+ 621.704) – 12.979 (+ 11.690) BIC4 – 602.395 (+ 259.165) LP1  
 – 0.001 (+ 0.000) PIPC10 + 16.683 (+ 15.675) VEA1  
 – 193.821 (+ 102.648) X5AV – 0.097 (+ 0.029) MPC10  
 - 0.075 (+ 0.023) EIG1M – 2.109 (+ 0.640) SEIGE + 0.112 (+ 0.038) MPC09  
 – 232.542 (+ 178.458) VEP2 + 0.074 (+ 0.028) VRP1 
 
Regression Equation for Model No.36 : 
logA = 2168.174 (+ 765.755) – 18.004 (+ 12.168) BIC4 – 854.825 (+ 319.015) LP1  
 - 0.001 (+ 0.000) PIPC10 + 35.663 (+ 21.075) VEA1  
 - 200.192 (+ 101.681) X5AV - 0.105 (+ 0.030) MPC10  
 - 0.057 (+ 0.026)EIG1M – 1.922 (+ 0.649) SEIGE + 0.101 (+ 0.039) MPC09  
 - 319.790 (+ 188.368) VEP2 + 0.054 (+ 0.032) VRP1 – 0.004 (+ 0.003) BAC 
Regression Equation for Model No.37 : 
logA = 2585.068 (+ 742.443) – 21.696 (+ 12.226) BIC4 – 1021.705 (+ 310.696) LP1  
 - 0.001 (+ 0.000) PIPC10 + 49.688 (+ 19.831) VEA1  
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 - 179.361 (+ 103.439) X5AV + 0.099 (+ 0.030) MPC10  
 - 0.018 (+ 0.012) EIG1M – 1.459 (+ 0.602) SEIGE + 0.082 (+ 0.038) MPC09  
 - 498.307 (+ 159.364) VEP2 – 0.006 (+ 0.003) BAC 
 
Regression Equation for Model No.38 : 
logA = 1445.987 (+ 663.583) – 27.100 (+ 10.586) BIC4 – 717.297 (+ 274.463) LP1  
 - 0.001 (+ 0.000) PIPC10 + 25.844 (+ 17.866) VEA1  
 - 298.788 (+ 88.700) X5AV + 0.083 (+ 0.026) MPC10  
 - 0.063 (+ 0.023) EIG1M – 1.734 (+ 0.557) SEIGE + 0.106 (+ 0.034) MPC09  
 - 0.047 (+ 0.012) BAC + 0.109 (+ 0.024) VRP1 + 468.834 (+ 124.995) X0A 
 
Table 9.  Regression parameters for the proposed models 





F Q = R/S.E. 
33 0.759 0.575 0.461 0.5075 5.013 1.4955 
34 0.805 0.649 0.541 0.4680 6.044 1.7202 
35 0.810 0.656 0.551 0.4628 6.253 1.7502 
36 0.820 0.673 0.561 0.4579 6.002 1.7906 
37 0.804 0.647 0.539 0.4694 5.989 1.7129 
38 0.865 0.748 0.661 0.4024 8.635 2.1497 
 
Table10. Number of variables, R2 and R2A used in deciding optimum number of descriptors 
Variables used                R2                 R2A 
1 0.235 0.219 
2 0.290 0.259 
3 0.324 0.278 
4 0.400 0.345 
5 0.429 0.362 
6 0.468 0.391 
7 0.493 0.404 
8 0.518 0.419 
9 0.556 0.451 
10 0.591 0.481 
11 0.627 0.513 
12 0.655 0.536 
11 0.649 0.541 
12 0.660 0.543 
11 0.656 0.551 
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12 0.673 0.561 
13 0.750 0.654 
12 0.748 0.661 
 















1.  0.645 0.6983 0.72934 0.6598 0.66512 0.68512 0.47734 
2.  -1.053 -0.20213 -0.59346 -0.66626 -0.61027 -058658 -0.64871 
3.  -1.028 -0.83072 -0.84273 -0.90617 -0.8766 -0.87171 -0.96761 
4.  -1.011 -0.5853 -0.86775 -0.88153 -0.84843 -0.86962 -0.57546 
5.  -1.003 -0.64038 -0.79426 -0.86517 -0.77143 -0.60266 -0.89839 
6.  -1.003 -0.83974 -0.84849 -0.88785 -0.89443 -0.8019 -1.03004 
7.  -1.003 -0.63215 -0.62535 -0.74068 -0.71834 -0.58635 -0.8766 
8.  -0.992 -0.91025 -0.95011 -1.09043 -1.0665 -0.90482 -1.2021 
9.  -0.286 -0.95277 -0.33378 -0.18639 -0.27862 -0.49604 -0.27284 
10.  -1.01 -1.15035 -1.09711 -1.17573 -1.19748 -1.10013 -1.2624 
11.  -1.008 -0.56567 -0.64694 -0.73464 -0.72442 -0.79337 -1.08736 
12.  -0.612 -0.70379 -1.08209 -1.12943 -1.0743 -1.0488 -0.75199 
13.  -0.347 -0.74515 -0.98397 -0.91378 -0.95117 -1.02309 -0.85368 
14.  -1.038 -0.44434 -0.214 -0.12998 -0.15134 -0.19002 -0.19878 
15.  -0.605 -0.49053 -0.59073 -0.47531 -0.53221 -0.63888 -0.70262 
16.  0.005 -0.09461 -0.0474 -0.14753 -0.12338 -0.14877 -0.27945 
17.  -0.322 -0.9797 -0.63008 -0.62608 -0.65524 -0.54909 -0.28776 
18.  0.97 0.18356 0.73028 0.73794 0.71731 0.6067 0.7363 
19.  1.588 0.63322 0.77012 0.74005 0.76694 0.82206 0.95819 
20.  1.001 0.62532 0.65065 0.59871 0.61832 0.69457 0.58878 
21.  0.015 0.65595 0.74401 0.59936 0.67351 0.8352 0.84228 
22.  1.607 0.58051 0.43541 0.50786 0.57385 0.45962 0.80781 
23.  0.382 0.73955 0.79989 0.64863 0.76606 0.78066 0.42488 
24.  -0.008 -0.08723 0.09755 0.07836 0.09753 0.09904 0.09681 
25.  0.397 0.01175 -0.00057 0.02618 0.06088 0.07394 -0.0158 
26.  -0.297 -0.27448 -0.41926 -0.43545 -0.38549 -0.44121 -0.44103 
27.  - - - - - - - 
28.  0.391 -0.11391 -0.08724 -0.12858 -0.08851 -0.07055 0.11126 
29.  -0.588 -0.41253 -0.29328 -0.14231 -0.36262 -0.50487 -0.32441 
30.  -0.61 -0.03171 0.07028 0.03 0.05953 0.05963 0.20386 
31.  - - - - - - - 
32.  0.449 0.36676 0.06654 0.24138 0.15484 0.17411 0.38368 
33.  - - - - - - - 
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34.  -1.017 -0.27581 -0.34813 -0.44782 -0.30265 -0.18615 -0.63547 
35.  -1.022 -1.16166 -1.1392 -1.06745 -1.17981 -1.06618 -1.32752 
36.  -1.022 -1.08147 -0.97931 -0.87921 -1.00977 -0.93264 -1.20022 
37.  -0.264 0.01082 -0.22455 -0.05294 -0.10541 -0.42704 -0.01565 
38.  -0.988 -0.64675 -0.68913 -0.76226 -0.74796 -0.7201 -0.76913 
39.  -1.046 -0.93652 -1.19611 -1.09209 -1.13968 -1.22023 -0.99449 
40.  0.032 -0.5074 -0.36216 -0.14016 -0.18241 -0.29181 -0.08311 
41.  0.017 -0.35445 0.0051 -0.28899 -0.03924 0.21013 -0.23521 
42.  -0.011 0.13914 0.12489 0.26907 0.22127 -0.02892 0.36617 
43.  - - - - - - - 
44.  - - - - - - - 
45.  -0.589 -0.58476 -0.4968 -0.49077 -0.40055 -0.40308 -0.53955 
46.  -0.294 -0.29133 -0.67308 -0.69966 -0.64537 -0.69448 -0.44533 
47.  -0.316 -0.48595 -0.49623 -0.34995 -0.4647 -0.49484 -0.10756 
48.  -0.301 -0.17517 -0.09435 0.00193 -0.10431 -0.17468 -0.05073 
49.  -0.286 -0.25785 -0.35079 -0.3362 -0.37473 -0.31426 -0.24361 
50.  0.016 -0.62543 -0.4771 -0.55976 -0.49574 -0.47075 -0.49656 
51.  -0.576 -0.32439 -0.23805 -0.29729 -0.16106 -0.11348 -0.25358 
52.  -0.595 -0.78749 -0.80581 -0.8893 -0.93242 -0.80746 -0.54265 
53.  -0.574 0.32902 0.08534 0.26789 0.01155 -0.13626 -0.58995 
‘Obs’ refers to ‘Observed’, ‘Est’ refers to ‘Estimated’ 

















Figure 2. Observed versus estimated activity for model 33. 
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Figure 4. Observed versus estimated activity for model 35. 
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Figure 6. Observed versus estimated activity for model 37. 
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Figure 7. Observed versus estimated activity for model 38. 
 
Table 12. Regression between observed and estimated activity for the proposed models  
Model 39 : 
logA(Observed) = 7.20 x 10-13 (+ 0.077) + 1.0 (+ 0.127) logA(Predicted) 33 
  n = 48, R = 0.759, R2 = 0.575, R2A = 0.566, S.E. = 0.455177, F = 62.325 
Model 40 : 
logA(Observed) = 9.83 x 10-13 (+ 0.069) + 1.0 (+ 0.108) logA(Predicted) 34 
  n = 48, R = 0.805, R2 = 0.649, R2A = 0.641, S.E. = 0.413989, F = 84.952 
Model 41 : 
logA(Observed) = 7.25 x 10-13 (+ 0.068) + 1.0 (+ 0.107) logA(Predicted) 35 
  n = 48, R = 0.810, R2 = 0.656, R2A = 0.649, S.E. = 0.409429, F = 87.885 
Model 42 : 
logA(Observed) = 5.10 x 10-13 (+ 0.066) + 1.0 (+ 0.103) logA(Predicted)36  
  n = 48, R = 0.820, R2 = 0.673, R2A = 0.666, S.E. = 0.399456, F = 94.654 
Model 43 : 
logA(Observed) = 8.18 x 10-13 (+ 0.069) + 1.0 (+ 0.109) logA(Predicted) 37 
  n = 48, R = 0.804, R2 = 0.647, R2A = 0.639, S.E. = 0.415228, F = 84.172 
Model 44 : 
logA(Observed) = 1.01 x 10-12 (+ 0.057) + 1.0 (+ 0.086) logA(Predicted) 38 
  n = 48, R = 0.865, R2 = 0.748, R2A = 0.742, S.E. = 0.350981, F = 136.189 
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 It is worthy to mention that the aforementioned results and discussions are enough to 
establish the goodness of fit, but none establishes the goodness of prediction. The proposed 
models should be excellent model only when they have both excellent fit and excellent predictive 
power. The latter is now investigated by using the method of cross-validation [5-7]. The various 
cross-validated parameters estimated for the models 33-38 are given in Table 13. All the cross-
validated parameters, except SPRESS, are in favor of the proposed model. From Table 9 and 13 we 
observed that Se is the same as SPRESS and thus the latter parameter cannot be used in deciding 
the uncertainty of prediction. In such cases the uncertainty in prediction is judged from yet 
another cross-validated parameter viz., PSE. The lowest value of PSE decides the uncertainty of 
prediction. Needless to state the PSE is smallest for the proposed model. Hence, we can conclude 
that the proposed model 38 has significant fit and predictive power. 
 Further examination of the data presented in Table 13 indicates that in all the six models 
PRESS < SSY indicating that these models predict better than chance and thus they can be 
considered statistically significant. Furthermore, the ratio PRESS / SSY for the model 38 is 
smaller than 0.4 (0.3378) indicating it to be reasonable QSAR model. 
 
Table 13. Cross validation parameters for the proposed models 
Model PRESS SPRESS SSY R2cv PRESS/SSY PSE 
33 9.5305 0.5075 12.9130 0.2619 0.7381 0.4456 
34 7.8838 0.4680 14.5597 0.4585 0.5415 0.4053 
35 7.7111 0.4628 14.7324 0.4766 0.5234 0.4008 
36 7.3400 0.4579 15.1035 0.5140 0.4860 0.3910 
37 7.9311 0.4694 14.5124 0.4535 0.5465 0.4065 
38 5.6667 0.4024 16.7768 0.6622 0.3378 0.3436 
 
 At this stage, it is interesting to comment on R2A, which accounts for the adjacent of R2. It is 
a measure of the % explained variation in the dependent variable that takes into account the 
relationship between the number of cases and the number of independent variables in the 
regression model.  Whereas, R2 will always increase  when an independent variable is added. R2A 
will decrease if the added variable doesn’t reduce the unexplained variation enough to offset the 
loss of degrees of freedom. If a variable is added that does not contribute its fair share, the R2A 
will actually decline. A perusal of Table 10 shows that as we pass from a ten parametric model to 
12-parametric model, R2A go on increasing indicating that in each case the added parameter has 
enough contribution to the proposed model.  
 From the data presented in Table 8 we observed that all the six models contain one or more 
linearly correlated parameters. Thus, statistically they suffer from the deflect due to collinearity. 
However, such a problem was thoroughly investigated by Randic [8]. We have, therefore, used 
Randic recommendations to resolve the problem arising from co- linearity. Randic [8] stated that 
selection of the descriptors to be used in structure-property-activity studies should not be 
delegated solely to the computers although statistical criteria will continue to be useful for 
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preliminary screening of the descriptors taken from a large pool. Often in an automated selection 
of descriptors a descriptor will be discarded because it is highly correlated with another 
descriptor already selected. But what is important is not descriptor parallel to one another, that is, 
duplicate much of the same structural information but whether they in those parts that are 
important for structure-property-activity correlation. If they differ in the domain, which is 
important for the property / activity considered both descriptors should be retained. If they differ 
in parts that are not relevant for the correlation of considered in parts that are not relevant for the 
correlation of considered property / activity that one of them can be discarded. Therefore, 
following Randic [8] all the six models can be considered statistically significant. In this regard it 
is worthy to mention that some of the most obvious problems of severe multicollinearity are as 
follows: 
 (1) Incorrect size of the coefficients, 
 (2) A change in the values of the previous coefficient when a new variable is added to the 
model, 
 (3) Change in insignificant of a preciously significant variable when a new variable is added 
to the model, and  
 (4) An increase in the standard error of the estimate when a new variable is added to the 
model. 
 In the proposed models (33-38) none of these problems occur. Furthermore, all the variables 
occurring in the model have coefficients, which are significantly larger than their respective 
standard deviations. In view of the aforementioned discussion all these models are considered 
statistically significant.  
 In order to finalize our results it is worthy to comment on the degeneracy of the molecular 
described in the present study. A perusal of Table 3 shows that low to high degeneracy is present 
in all the molecular descriptors used. This due to the fact that these descriptors belong to first and 
second generation descriptors , which in spite of their degeneracy are quite useful in QSPR and 
QSAR studies [15].In our case the degeneracy problem has become more actuate due to the use 
of  descriptors LP1 and X5AV. Out of the 53 compounds used in the present study LP1 is found 
to be the same (2.639) value for as many as 49 compounds. While in the case of X5AV, its value 
is not widely varied, it ranges between 0.022 and 0.025.Furthermore both these parameters are 
involved in all the six (33-38) statistically significant models. However, we observed that use of 
these parameters in the proposed models is well justified due to increase in R2A upon their 
addition as the correlating parameters. Furthermore, in all the six models these parameters have 
coefficients very much larger than their corresponding standard divisions and those models are 
statistically allowed. However, it seems beneficial to confirm our results by further performing 
regressions without considering LP1 or X5AV or both. If, under such a study the quality of the 
regression is improved, then it will be better to do modeling without these parameters, otherwise 
not. When we did so (Tables 14-19) we observed that under such study the models become quite 
inferior without the use of these parameters. All these results, therefore, justifies the use of these 
two parameters in all the models proposed by us. 
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Modified models 33 – 38 after deleting LP1 or X5AV or both variables 
Table 14. Regression parameters for models 33 – 38 after deleting LP1  
Models R R2 R2A Standared Error (SE) F Q= R/SE 
33 0.6929 0.6929 0.3570 0.5541 3.8998 1.2505 
34 0.7105 0.5049 0.3710 0.5480 3.7727 1.2965 
35 0.7267 0.5281 0.4005 0.5350 4.1402 1.3582 
36 0.7270 0.5285 0.3844 0.5422 3.6679 1.3408 
37 0.7038 0.4953 0.3589 0.5533 3.6314 1.2720 
38 0.7840 0.6146 0.4969 0.4902 5.2195 1.5994 
 
Table 15. Cross Validation parameters for models 33 – 38 after deleting LP1  
Models PRESS SPRESS SSY R2CV PRESS/SSY PSE 
33 29.2527 0.8774 47.0000 0.3776 0.6224 0.7807 
34 28.1088 0.8716 47.0000 0.4019 0.5981 0.7652 
35 27.0600 0.8552 47.0000 0.4243 0.5757 0.7508 
36 27.0424 0.8667 47.0000 0.4246 0.5754 0.7506 
37 28.5472 0.8784 47.0000 0.3926 0.6074 0.7712 
38 23.3385 0.8052 47.0001 0.5034 0.4966 0.6973 
 
Table 16. Regression parameters for models 33 – 38 after deleting X5AV 
Models R R2 R2A Standared Error (SE) F Q= R/SE 
33 0.7207 0.5194 0.4056 0.5328 4.5638 1.3528 
34 0.7397 0.5471 0.4247 0.5241 4.4701 1.4113 
35 0.7405 0.5484 0.4263 0.5234 4.4930 1.4149 
36 0.7648 0.5849 0.4581 0.5087 4.6118 1.5034 
37 0.7629 0.5820 0.4690 0.5035 5.1516 1.5150 
38 0.7829 0.6130 0.4947 0.4912 5.1833 1.5939 
 
Table 17. Cross Validation parameters for models 33 – 38 after deleting X5AV 
Models PRESS SPRESS SSY R2CV PRESS/SSY PSE 
33 27.4474 0.8499 47.0000 0.4160 0.5840 0.7562 
34 26.2159 0.8417 47.0000 0.4422 0.5578 0.7390 
35 26.1604 0.8409 47.0000 0.4434 0.5566 0.7382 
36 24.5844 0.8264 47.0001 0.4769 0.5231 0.7157 
37 24.7086 0.8172 47.0000 0.4743 0.5257 0.7175 
38 23.4070 0.8063 47.0000 0.5020 0.4980 0.6983 
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Table 18. Regression parameters for models 33 – 38 after deleting LP1 and X5AV 
Models R R2 R2A Standared Error (SE) F Q= R/SE
33 0.6574 0.4321 0.3156 0.5717 3.7096 1.1499 
34 0.6877 0.4730 0.3482 0.5579 3.7893 1.2327 
35 0.7028 0.4939 0.3740 0.5467 4.1200 1.2854 
36 0.7030 0.4942 0.3575 0.5539 3.6151 1.2692 
37 0.6866 0.4714 0.3462 0.5588 3.7652 1.2288 
38 0.7387 0.5457 0.4229 0.5250 4.4437 1.4071 
 
Table 19. Cross Validation parameters for models 33 – 38 after deleting LP1 and X5AV 
Models PRESS SPRESS SSY R2CV PRESS/SSY PSE 
33 31.5632 0.8996 47.0000 0.3284 0.6716 0.8109 
34 29.5900 0.8824 47.0000 0.3704 0.6296 0.7851 
35 28.6141 0.8678 46.9999 0.3912 0.6088 0.7721 
36 28.5991 0.8792 47.0000 0.3915 0.6085 0.7719 
37 29.6652 0.8836 47.0001 0.3688 0.6312 0.7861 





From the results and discussion made above we conclude that antimycobacterial activity of 3-
formyl rifamycin SV derivatives can be modeled using a twelve-parametric model which 
contains variety of molecular descriptors including distance-based and connectivity indices. The 
results obtained here in will be useful for pharmaceutical as well as medicinal chemists to 





(1) Antimycobacterial activity: The antimycobacterial activity expressed as log(MICRIA/MICX) 
for different strains against Mycobacterium tuberculosis were taken from the literature [4]. For 
the brevity this activity in all the tables as well as in the text is expressed as logA. Further details 
are available in [4]. 
(2) Molecular descriptors: All the molecular descriptors used for proposing statistically 
significant models were calculated using DRAGON Software [11] . The structure optimization 
was performed using ACD Labs [12] and HyperChem [13] software’s. 
(3) Statistical analysis: All the statistical analyses were performed using SPSS Software [14]. 
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